Diabetes technology

Degree of islet function preservation and continuous glucose monitoring in individuals undergoing total pancreatectomy with islet autotransplantation

DiabetologiaPublished Cohort study

Authors' conclusion

Nearly half of islet secretory function is retained after TPIAT.

Study context

Population
Individuals undergoing TPIAT from 2014 to 2024; 88.5% chronic pancreatitis; at baseline 57.7% prediabetes or diabetes, 46.2% previous pancreatic surgery
Participants
26 individuals
Outcome
Islet secretory function (C-peptide AUC on 2 h liquid meal stimulation test) relative to baseline
Follow-up
3 months post TPIAT
Methodological detailsEligibility for TPIAT assessed by a multidisciplinary team
  • Eligibility for TPIAT assessed by a multidisciplinary team

Main finding

As reported in the abstract

Islet secretory function (C-peptide AUC), % of baseline

C-peptide AUC as % of baseline

45%

Observational data: associations, not effects.

Further findings

TIR (CGM) · 3 months

TIR, mean ± SD
75.2 ± 26.1%
TIR positively correlated with C-peptide AUC
P < 0.0001

Islet function after 3 months

Islet function did not significantly change; stable BETA-2 score

Original publication

Degree of islet function preservation and continuous glucose monitoring in individuals undergoing total pancreatectomy with islet autotransplantation. Diabetologia. Published 27 June 2026. doi:10.1007/s00125-026-06772-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.